Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swedish Orphan Biovitrum AB

www.sobi.com

Latest From Swedish Orphan Biovitrum AB

Hansa Medical CEO Arvidson Dies

Hansa Medical announces the sudden death of its CEO Göran Arvidson.

Companies Commercial

Pipeline Watch: Risankizumab, Viaskin Peanut, Symtuza Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Approvals Pipeline Watch

New CEO Revamps Top Team, Specialty Care Business At Sobi

The new CEO of Sweden's rare diseases company sets up an executive team, highlights its specialty business, and forecasts a better 2017 than previously thought.

Business Strategies Companies

Pipeline Watch: Phase III Readouts For Gilenya, Duvelisib, Trimbow

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Sobi
  • Biovitrum AB
  • Swedish Orphan Biovitrum
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Swedish Orphan Biovitrum AB
  • Senior Management
  • Guido Oelkers, PhD, Pres. & CEO
    Mats-Olof Wallin, SVP, CFO
    Stefan Fraenkel, PhD, SVP, Head, Corp. Dev.
    Milan Zdravkovic, SVP, Head, R&D
  • Contact Info
  • Swedish Orphan Biovitrum AB
    Phone: (46) 8 697 20 00
    Tomtebodavägen 23A
    Stockholm, SE-112 76
    Sweden
Advertisement
Advertisement
UsernamePublicRestriction

Register